Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2685 blog entries.

New York

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the March 2022 Medicaid Update.  

You may also go straight to an article or topic that pertains to you by selecting it from the current issue's table of contents below.  

 Policy and Billing 

  

All Providers 

  

Pharmacy 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-04-22T09:17:58-04:00April 22, 2022|New York|

Ohio

The Department of Medicaid (ODM) held its second stakeholder webinar regarding the implementation of the Single Pharmacy Benefits Manager (SPBM) under the Next Generation of Managed Care program on April 15. The subject matter was the new Specialty Drug Program. Copies of the PowerPoint slides and other information regarding the program can be found on ODM’s SPBM webpage. The slides state the next webinar will be held in early May and will cover SPBM pricing.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-04-22T09:16:54-04:00April 22, 2022|Ohio|

Pennsylvania

Long-awaited Board of Pharmacy regulations allowing pharmacy interns to immunize have been released in final form by the Independent Regulatory Review Commission (IRRC), where they are scheduled for a vote on May 19. After IRRC passage, the regulations will go to the Attorney General and be published in the Pennsylvania Bulletin. The regulations will be final 30 days after the official publication date. The rulemaking is pursuant to the Pharmacy Act amendments made by Act 8 of 2015, the same law that allowed pharmacists to administer influenza vaccines to children aged 9 years and older.  

Also in Pennsylvania, the PACE program issued a bulletin regarding Program audit procedures. It includes clarification regarding who is responsible for providing information related to the requested documents. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-04-22T09:16:10-04:00April 22, 2022|Pennsylvania|

South Carolina

The Board of Pharmacy is having supply chain issues with the paper it uses for licenses. The paper currently being used does not provide the perforated wallet card. However, it does allow for the wallet card to be cut out and used for business purposes. The Pharmacy Board inspectors are aware of the change with the licensing paper. This will not affect pharmacists’ ability to practice.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-22T09:15:12-04:00April 22, 2022|South Carolina|

Tennessee

Gov. William Lee (R) signed SB 2446/HB 2131 into law on April 8, effective immediately, the legislation modernizes the definition of pharmacy technicians and now clearly allows a pharmacist to delegate tasks to a technician based on their education, training, and support, allowing all members of the pharmacy team to practice at the top of their education and training.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-22T09:09:31-04:00April 22, 2022|Tennessee|

Virginia

Gov. Glenn Youngkin (R) amended companion bills HB 1323 and SB 672 to add language in that was removed during the legislative process allowing pharmacists to test and treat for flu, strep and urinary tract infections (UTIs). Our original language that codifies pharmacies’ immunization and testing authority allowances under the PREP Act remains intact. The bill also allows pharmacists to initiate tobacco cessation therapy, including prescription drugs. These bills will now have to go before the Legislature on April 27 to approve or reject the governor’s recommendation on the amended language. NACDS applauds the Virginia Association of Chain Drug Stores (VACDS) and the Virginia Retail Federation (VRF) for all the groundwork on this bill and to members for your outreach to the Governor’s office.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-04-22T09:08:55-04:00April 22, 2022|Virginia|

Wisconsin

Effective immediately, Dr. Jasmine Zapata is the new Wisconsin physician signing the Statewide Standing order for Naloxone. You must use Dr. Zapata's prescriber number going forward as Dr. Jon Meiman's prescriber number can no longer be used. In addition, the Wisconsin Department of Health Services (DHS) has updated its web pages. 

Under this new standing order, there are new resources available through the enhanced Dose of Reality Initiative. Patient education regarding overdose recognition and naloxone administration can be found on the following web pages: 

If you have questions, reach out to: DHSOpioids@dhs.wisconsin.gov

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-04-22T09:08:11-04:00April 22, 2022|Wisconsin|

Alabama

The Alabama Department of Public Health has stated that allocation quantities of Paxlovid and Lagevrio (molnupiravir) have increased. ADPH has expanded access to most of the chain pharmacies and several independent pharmacies. If you are interested in being an oral antiviral provider, please review the information below. 

Pharmacies interested in dispensing Paxlovid and/or Lagevrio (molnupiravir) for the treatment of COVID-19 should send an email to pharmacy@adph.state.al.us. The Pharmacy Division at the Alabama Department of Public Health will provide information and assist with setting up an HPOP account which is required by HHS. Through this account, pharmacies will report utilization daily which is also required by HHS. The Fact Sheet for Paxlovid can be found here. The Fact Sheet for Lagevrio (molnupiravir) can be found here. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-01T12:54:18-04:00April 1, 2022|Alabama|

Arizona

Governor Doug Ducey (R) signed SB 1309 (Chapter 77), extending temporary licenses issued during the COVID-19 emergency declaration and active on March 1, 2022; they do not expire until January 1, 2023. 

Also in Arizona, Gov. Ducey announced the end of the COVID-19 emergency declaration. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-01T12:49:56-04:00April 1, 2022|Arizona|
Go to Top